Clinical Trial Update: Phase I/II Study of FR104 First Administration In Patient With Renal Transplantation: FIRsT Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II study (FIRsT) of FR104 in kidney transplantation has completed its Phase 1/Phase 2 activities, including first administration in patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• FR104

Snippet

Sponsor: Nantes University Hospital | Conditions: Kidney Transplantation | Phase 1, Phase 2 | Status: COMPLETED